Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$576,703
+$175,264 QoQ
Shares Held
1,161
+29.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,023
of 1,735 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. VRTX ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
306,330 | $24,288,904 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
579,882 | $22,621,196 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
260,730 | $15,737,662 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
277,952 | $15,159,500 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
245,390 | $14,041,214 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
679,445 | $12,209,626 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,242 | $10,127,536 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
286,952 | $9,581,327 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $576,703 | 1,161 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $401,439 | 899 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,705,539 | 3,762 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,988,070 | 10,183 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,917,598 | 13,292 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $585,661 | 1,208 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,224,610 | 3,041 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,380,822 | 2,969 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,033,611 | 15,006 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $3,596,975 | 8,605 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $12,462,225 | 30,628 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $3,639,099 | 10,465 | Shares | Sole | 2024-10-21 | |
| 2023-06-30 | $2,563,664 | 7,285 | Shares | Sole | 2024-10-21 | |
| 2022-09-30 | $555,047 | 1,917 | Shares | Sole | 2022-11-07 | |
| 2022-03-31 | $272,713 | 1,045 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,989,472 | 18,167 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $372,189 | 1,732 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $342,598 | 1,259 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||